Cargando…
Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial
Laryngospasm is an important complication of tonsillectomies. This study aimed to compare the effects of propofol versus lidocaine on prevention of laryngospasm in tonsillectomy. This randomized clinical trial included 102 patients who met the inclusion criteria. Patients were randomly divided into...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580534/ https://www.ncbi.nlm.nih.gov/pubmed/35766592 http://dx.doi.org/10.4081/ejtm.2022.10581 |
_version_ | 1784812408653479936 |
---|---|
author | Manouchehrian, Nahid Jiryaee, Nasrin Moheb, Faezeh Akbari |
author_facet | Manouchehrian, Nahid Jiryaee, Nasrin Moheb, Faezeh Akbari |
author_sort | Manouchehrian, Nahid |
collection | PubMed |
description | Laryngospasm is an important complication of tonsillectomies. This study aimed to compare the effects of propofol versus lidocaine on prevention of laryngospasm in tonsillectomy. This randomized clinical trial included 102 patients who met the inclusion criteria. Patients were randomly divided into two groups treated with 0.5 mg/kg propofol (group P) or 1 mg/kg lidocaine 2% (group L). The frequencies of laryngospasm (within 10 min after extubation), agitation, nausea, vomiting, mean heart rate and mean arterial pressure (MAP) were assessed in both groups. Data were analyzed using SPSS software version 16 at a 95% confidence level. There were no significant differences between the two groups in terms of sex, age or weight. In the P group, the frequency of laryngospasm was significantly lower than L within10 minutes after extubation (4.1% versus 16.3%). Furthermore, the frequencies of agitation (p = 0.003), nausea and vomiting (p = 0.002) and mean heart rate (p = 0.026) were significantly higher in the L group than the P group. However, there were no differences between the two groups in terms of mean systolic and diastolic blood pressure, MAP, SPO(2), awakening time, length of stay in recovery and frequency of shivering. Propofol can reduce the incidence of laryngospasm, agitation, nausea and vomiting but it has no effect on the patient's awakening time and length of stay in recovery. |
format | Online Article Text |
id | pubmed-9580534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-95805342022-10-20 Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial Manouchehrian, Nahid Jiryaee, Nasrin Moheb, Faezeh Akbari Eur J Transl Myol Article Laryngospasm is an important complication of tonsillectomies. This study aimed to compare the effects of propofol versus lidocaine on prevention of laryngospasm in tonsillectomy. This randomized clinical trial included 102 patients who met the inclusion criteria. Patients were randomly divided into two groups treated with 0.5 mg/kg propofol (group P) or 1 mg/kg lidocaine 2% (group L). The frequencies of laryngospasm (within 10 min after extubation), agitation, nausea, vomiting, mean heart rate and mean arterial pressure (MAP) were assessed in both groups. Data were analyzed using SPSS software version 16 at a 95% confidence level. There were no significant differences between the two groups in terms of sex, age or weight. In the P group, the frequency of laryngospasm was significantly lower than L within10 minutes after extubation (4.1% versus 16.3%). Furthermore, the frequencies of agitation (p = 0.003), nausea and vomiting (p = 0.002) and mean heart rate (p = 0.026) were significantly higher in the L group than the P group. However, there were no differences between the two groups in terms of mean systolic and diastolic blood pressure, MAP, SPO(2), awakening time, length of stay in recovery and frequency of shivering. Propofol can reduce the incidence of laryngospasm, agitation, nausea and vomiting but it has no effect on the patient's awakening time and length of stay in recovery. PAGEPress Publications, Pavia, Italy 2022-06-29 /pmc/articles/PMC9580534/ /pubmed/35766592 http://dx.doi.org/10.4081/ejtm.2022.10581 Text en https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Manouchehrian, Nahid Jiryaee, Nasrin Moheb, Faezeh Akbari Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial |
title | Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial |
title_full | Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial |
title_fullStr | Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial |
title_full_unstemmed | Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial |
title_short | Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial |
title_sort | propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: a randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580534/ https://www.ncbi.nlm.nih.gov/pubmed/35766592 http://dx.doi.org/10.4081/ejtm.2022.10581 |
work_keys_str_mv | AT manouchehriannahid propofolversuslidocaineonpreventionoflaryngospasmintonsillectomyarandomizedclinicaltrial AT jiryaeenasrin propofolversuslidocaineonpreventionoflaryngospasmintonsillectomyarandomizedclinicaltrial AT mohebfaezehakbari propofolversuslidocaineonpreventionoflaryngospasmintonsillectomyarandomizedclinicaltrial |